FDAnews
www.fdanews.com/articles/180594-chaffetz-vows-subpoena-if-mylan-foot-dragging-continues

Chaffetz Vows Subpoena If Mylan Foot-Dragging Continues

February 17, 2017

The House Oversight Committee threatened to subpoena Mylan for full documents related to price increases for its EpiPen.

In a letter to Mylan’s attorney, Committee Chairman Rep. Jason Chaffetz (R-Utah) faulted Mylan for giving the committee only “a limited subset” of requested documents pertaining to production and distribution of the company’s EpiPen.

Chaffetz demanded the full, unredacted requested documentation in-camera by the end of February.

View today's stories